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Abstract. In February 1998, an outbreak of acute febrile illness was reported from the Kapalata military camp in
Kisangani, the Democratic Republic of Congo. The illness was characterized by an acute onset of fever associated
with severe headache, arthralgia, backache, neurologic signs, abdominal pain, and coughing. In 1 individual, hem-
orrhagic manifestations were observed. The neurologic signs included an altered level of consciousness, convulsions,
and coma. Malaria was initially suspected, but the patients showed negative blood films and failed to respond to
antimicrobial drugs. A total of 35 sera collected from the military patients in the acute phase were tested for the
presence of IgM against vector-borne agents. Serum IgM antibodies against West Nile fever virus were found in 23
patients (66%), against Chikungunya virus in 12 patients (34%), against dengue virus in 1 patient (3%), and against
Rickettsia typhi in 1 patient (3%). All sera were negative for IgM antibody against Rift Valley fever virus, Crimean
Congo hemorrhagic fever virus, and Sindbis virus. These data suggest that infections with West Nile fever virus have
been the main cause of the outbreak.
Infections with arthropod-borne viruses are emerging as
a major public health problem in many parts of the
world.1,2 In sub-Saharan African countries such as in
Zaire,3 Uganda,4 Sudan,5,6 and Kenya,7 several outbreaks
of febrile illness have been associated with arbovirus in-
fections. Both sporadic and major outbreaks of West Nile
fever have also been reported in Europe, with the largest
in Romania, which had 393 serologically confirmed cas-
es.8 In Bucharest alone more than 90,000 residents were
infected during this epidemic. The presence of mosquitoes
in houses and flooding of basements were identified as
risk factors for infection with West Nile virus.9 Most re-
cently, an outbreak of Rift Valley fever with a high mor-
tality rate was reported from Somalia, Kenya, and Mau-
ritania involving thousands of humans and animals.10 En-
tomologic studies conducted in large areas of the African
continent have identified numerous arthropods that may
be involved in the transmission of arboviruses, and viro-
logic investigations have identified more than 40 of the
approximately 100 arboviruses that are known to cause
human disease to be present in Africa.11,12 Despite this
knowledge, events that led to the presently observed in-
crease of arbovirus infections in Africa have not been ex-
tensively investigated. However simultaneous environ-
mental changes, presence of infected vectors, vector den-
sity, increased travel, and presence of non-immune hosts
has been considered to be major factors responsible for
this increase.13 The construction of dams in Egypt and
Mauritania,14,15 flooding in Somalia, as well as heavy rain
falls in several locations have contributed to the increase
of breeding sites of several Aedes species in Africa.
In Kisangani, Democratic Republic of Congo, an outbreak
of acute febrile illness was recently observed among military
personnel recruited from other regions and recently stationed
in a nearby military camp. Clinical identification was facil-
itated by the intensive symptomatology experienced by the
military patients (Table 1). The aim of the present study was
to explore whether an arbovirus infection was involved in
this outbreak.
MATERIALS AND METHODS
Study site. The study was conducted in Kisangani, the
capital city of Province Oriental in the central/eastern part
of Democratic Republic of Congo. Cases were selected from
a military camp, Kapalata, situated at the outskirts of the
town. The Kapalata camp was reported to contain approxi-
mately 2,000 males between 12 and 40 years of age recently
recruited from other regions of the country. Comprehensive
demographic data were unavailable due to impeded access
to the camp. Prior to the febrile illness outbreak, a cholera
epidemic in the Kapalata camp was reported to Me´decins
Sans Frontie`res (MSF: an international non-governmental
organization). This prompted the organization to set up a
temporary inpatient department (IPD) facility next to the
general hospital to provide care for the large number of pa-
tients (approximately 300 at the time) from the Kapalata
camp.
Clinical observations. Only patients who developed
symptoms while living within the premises of the camp and
admitted to the MSF IPD facility were considered as cases.
Upon initial examination, patients were found to be febrile
(temperature . 38.58C), acutely ill with neurologic symp-
toms or in shock, and frequently complaining of headache,
arthralgia, abdominal pain, cough, and occasional diarrhea.
Virtually all cases were malnourished. Except for 1 case,
hemorrhagic manifestations were not observed. Those cases
suspected or confirmed for malaria were treated accordingly
before a focused investigation was started. An increase in
febrile illness was also reported from health centers in Ki-
sangani. Thus, additional samples were collected from Ki-
sangani residents.
Serum samples. Sera were obtained from 35 acutely ill
camp patients admitted to the MSF-IPD facility within 2
weeks after the onset of the symptoms. One patient comply-
ing with the case definition (see results) could not be sam-
pled since he died with hemorrhagic symptoms before being
sampled. In addition, 10 sera were collected from acutely ill
local residents who were seen in several health facilities in
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TABLE 1
Clinical presentation of patients probably involved with the outbreak
Symptoms*
Kapalata military
camp
(n 5 35) (%)
Kisangani general
hospital
(n 5 10) (%)
Acute fever
Headache
CNS involvement
Abdominal pain
Arthralgia
Respiratory signs
Convulsions
30
18
16
15
13
8
4
86
51
46
43
37
23
11
10
2
0
6
1
0
0
100
20
00
60
10
0
0
* CNS 5 central nervous system.
Kisangani. These residents included 4 children less than 5
years of age with symptoms similar to those of the camp
patients. Samples were sent for analysis to the World Health
Organization Reference Center for Arboviruses and Hem-
orrhagic Fever Viruses in Rotterdam, The Netherlands. The
samples were taken at different time points and sent in
batches. Two batches of 9 individual serum samples were
obtained on February 4 and 6, 1998. Another 2 batches of
9 and 8 serum samples were obtained on February 10 and
26, 1998. The last batch of 10 serum samples was obtained
from long-time Kisangani resident patients on March 3,
1998. The time lapse between collection of a sample and
analysis varied from 1–2 weeks. Field circumstances did not
allow for transport under appropriate temperature conditions.
The following viruses were considered as the possible caus-
ative agents in the present study: West Nile fever virus, Chi-
kungunya virus, dengue virus, Crimean-Congo hemorrhagic
fever virus, Rift Valley fever virus, yellow fever virus, and
Sindbis virus. Rickettsia typhi was also considered in the
study because of clinical symptoms in combination with the
presence of human body lice.
All serum samples were collected after patients were in-
formed that their samples would be used for diagnostic pur-
poses to identify the cause of the apparently circulating dis-
ease, and after their informed consent was obtained. This
study was approved by the Ethical Committee of the Uni-
versity Hospital Rotterdam.
Detection of IgM antibodies. For the detection of IgM
antibodies against dengue virus (types 1–4), West Nile virus,
yellow fever virus, and Sindbis virus, an IgM capture ELISA
was used as previously described.6,16,17 IgM antibodies
against Rift Valley fever virus, Chikungunya virus, Crimean
Congo hemorrhagic fever virus, and R. typhi were measured
by an indirect immunofluorescence assay as described.18,19
Detection of IgG antibodies. For the detection of IgG
antibodies against dengue virus types 1–4 and West Nile
virus, an indirect ELISA was used as previously de-
scribed.16,17 Binding of the IgG antibodies was detected using
goat anti-human IgG antibodies labeled with horseradish
peroxidase. IgG antibodies against Chikungunya virus, Cri-
mean Congo hemorrhagic fever virus, Sindbis virus, yellow
fever virus, Rift Valley fever virus, and R. typhi were mea-
sured by an indirect immunofluorescence assay as de-
scribed.18,19
Virus isolation. Although the serum samples were not
transported under appropriate temperature conditions, an at-
tempt was made to isolate virus from the serum samples
using methods available for isolation including mouse and
cell culture inoculations.20
RESULTS
Clinical findings. The most prominent symptoms of the
patients are summarized in Table 1. Acute fever was ob-
served in 30 (86%) of 35 patients from the Kapalata camp,
headache in 18 (51%), central nervous system involve-
ment in 16 (46%), abdominal pain in 15 (43%), arthralgia
in 13 (37%), respiratory infection in 8 (23%), and con-
vulsions in 4 (11%). In patients from Kisangani, 10
(100%) had acute fever, 6 (60%) had abdominal pain, 2
(20%) had headache, and 1 (10%) had arthralgia. None of
these patients had central nervous system involvement.
Based on these findings a case was defined as a patient
with acute fever, headache, neurologic symptoms, abdom-
inal pain, and arthralgia. Hemorrhagic manifestations (n
5 1) and convulsions (n 5 4) were present in some of the
patients. All patients investigated developed symptoms
while in the Kapalata camp.
Serum from Kapalata camp patients. Screening of the
35 serum samples collected from acutely ill camp patients
showed that 23 (66%) had IgM and IgG antibodies against
West Nile fever virus, and 12 (34%) had IgM and IgG an-
tibodies against Chikungunya virus. Only 1 (3%) serum had
IgM and IgG antibodies against dengue virus, and 1 other
(3%) sample contained IgM and IgG antibodies against R.
typhi. Three patients showed IgM reactivity against yellow
fever virus; however, these patients had a higher reactivity
against West Nile fever virus compared with yellow fever
virus, indicating that these were probably antibodies with a
low degree of cross-reactivity.
Serum from Kisangani residents. Of the 10 patients
from the health centers of Kinsingani, IgM and IgG anti-
bodies against dengue virus were found in 3 (30%), against
West Nile fever virus in 1 (10%), against Chikungunya virus
1 (10%), and against R. typhi in 2 (20%). A high prevalence
of IgG antibodies against West Nile fever virus (8 of 10)
and Chikungunya virus (6 of 10) was found among the Ki-
sangani patients. In addition, 2 patients had IgG antibodies
against Rift Valley fever virus. Overall serologic results are
shown in Figure 1 according to the date of sampling.
Virus isolation. Only 17 of 45 samples could be used for
virus isolation. Virus was not isolated from any of the sam-
ples tested.
DISCUSSION
Many cases in Africa that present with fever are docu-
mented as fever of unknown origin, especially if they fail to
respond to antimicrobial drugs. The majority of these con-
ditions remain undiagnosed. However, several arboviruses
are frequently considered in the etiology of acute febrile ill-
ness. Two main factors known to favor the emergence of
vector-borne diseases were present at our study site, which
led us to consider a possible role of arbovirus infection in
the etiology of this particularly severe febrile illness. First,
the outbreak was preceded by heavy rainfall, resulting in
flooding in and around the city of Kisangani, providing an
ideal breeding site for the vector mosquito (Culex), which
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FIGURE 1. IgM and IgG antibodies against West Nile virus (white bars), Chikungunya virus (checkered bars), dengue virus (diagonal
bars), and Rickettsia typhi (gray bars) among patients in the Kapalata camp and Kisangani residents.
transmits West Nile virus. Second, the military patients re-
cently recruited were probably from an area nonendemic for
West Nile virus and formed a newly introduced pool of sus-
ceptible individuals.
In this study, the detection of high titers of IgM antibody
against West Nile virus and the intensity of the clinical
symptomatology among patients from the Kapalata camp in-
dicated that these patients had not been previously exposed
to this virus. Low-titer IgM antibodies against West Nile
virus were detected in only 1 serum sample from a local
patient. This sample was also positive for IgM antibodies
against dengue virus. Furthermore, the majority (9 of 10) of
the patients from local areas had high IgG antibodies titers
against West Nile virus, which rules out active West Nile
virus transmission and suggests previous exposure to the vi-
rus by long-time residents of Kisangani. With the exception
of Koutango and Usutu viruses, no extensive studies of other
flaviviruses that serologically cross-react with West Nile vi-
rus have been reported from this area. However, only 1 case
of human infection with Usutu virus has ever been reported
from Africa,21 and there is no naturally acquired human dis-
ease associated with Koutango virus.21
We conclude that high titers of IgM antibodies against
West Nile virus in 66% of the febrile camp patients is in-
dicative of active transmission of West Nile virus among
these patients. Although confirmation by virus isolation
could not be accomplished, our study suggests that West Nile
fever virus or an antigenically closely related virus was the
main cause of the outbreak of severe febrile illness among
the Kapalata camp population in Kisangani, Democratic Re-
public of Congo.
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